News
Sunny Pharmtech has a US sales agreement with a Pharmaceutical Company S, targeting a $2.4 Billion opportunity in Pulmonary Fibrosis Medication
05/03 Sunny Pharmtech has a US sales agreement with a Pharmaceutical Company S, targeting a $2.4 Billion opportunity in Pulmonary Fibrosis Medication